| Q41715189 | A clinical study of chronic depression. |
| Q51267813 | A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. |
| Q47423314 | A cross-cultural study of depressive symptomology |
| Q36673055 | Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. |
| Q41445959 | Affective disorder in alcoholism |
| Q35592505 | Clinical consequences of under-recognized bipolar spectrum disorder |
| Q40226725 | Cognitive functioning in depression: a review of theory and research. |
| Q36974468 | Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder |
| Q36844230 | Conversion from bipolar disorder not otherwise specified (BP-NOS) to bipolar I or II in youth with family history as a predictor of conversion |
| Q36204951 | Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression |
| Q52123213 | Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. |
| Q42671085 | Do patients with borderline personality disorder belong to the bipolar spectrum? |
| Q51185291 | Gender-specific association of the SLC6A4 and DRD2 gene variants in bipolar disorder. |
| Q48417098 | Genotype variant associated with add-on memantine in bipolar II disorder |
| Q42273469 | Hypomanic reaction to amitriptyline in a depressed child |
| Q35772818 | Impact of medical comorbid disease on antidepressant treatment of major depressive disorder |
| Q28534387 | Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder |
| Q38688656 | Mixed features in major depressive disorder: diagnoses and treatments |
| Q60628590 | Neuroendocrine Evaluation of Depression in Borderline Patients |
| Q33638848 | Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide |
| Q89100693 | Prospective: Is bipolar disorder being overdiagnosed? |
| Q60626418 | Psychopathology in the families of inpatient affective disordered adolescents |
| Q43931805 | Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers |
| Q34106678 | Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders |
| Q51032825 | Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. |
| Q92932846 | Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder |
| Q31951578 | Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues |
| Q71838818 | Suicide prevention: the necessity of treating contributory psychiatric disorders |
| Q31951593 | Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). |
| Q37220454 | The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders. |
| Q28076486 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines |
| Q58565238 | The correlation between longitudinal changes in hypothalamic-pituitary-adrenal (HPA)-axis activity and changes in neurocognitive function in mixed-state bipolar II disorder |
| Q37460196 | The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism |
| Q33768203 | The evolving bipolar spectrum. Prototypes I, II, III, and IV. |
| Q48561637 | The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder |
| Q33962900 | The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions |
| Q51032804 | Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. |
| Q72549787 | Trends in Research and Treatment of Affective Disorders |